Ironwood appoints Tammi Gaskins as CEO, Tom McCourt to retire in 2027
Ironwood Pharmaceuticals announced that Chief Commercial Officer Tammi Gaskins will become chief executive officer on January 1, 2027, succeeding Tom McCourt, who will retire from the role after 17 years but remain on the board. The board said Gaskins’ commercial track record, especially the LINZESS turnaround, positions her to lead the company through its next growth phase. The transition was disclosed in an SEC filing and confirmed by multiple news outlets on October 16, 2026.
Why it matters
Investors reacted negatively, with the stock falling 3.7% in after‑hours trading and 4.6% during the day. The decline reflects market uncertainty about the pipeline and leadership change.
Key facts
- 1Tammi Gaskins will assume the CEO role on January 1, 2027. stocktitan.net
- 2Tom McCourt will retire as CEO after 17 years but will stay on the board. stocktitan.net
- 3Gaskins has been Ironwood’s Chief Commercial Officer since 2020 and led the LINZESS turnaround. stocktitan.net
- 4Ironwood’s board size will increase to nine members after Gaskins joins the board. tradingview.com
- 5Shares dropped 3.7% after the announcement. investing.com
- 6Shares fell 4.6% in mid‑day trading, reaching a session low of $3.56 and trading at $3.60. investing.com
Summary written by AlphAI AI Desk from 8 of 8 sources. Not investment advice. Figures are as stated by the linked sources.